ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,339.23
-0.37%
Dow Jones
39,057.40
-1.55%
Gold vs US Dollar
2,333.72
-2.02%
Brent Oil
81.145
-0.47%
Bitcoin
67,295.24
-2.62%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Corcept Therapeutics Inc (CORT)

  7. Corcept Therapeutics Inc (CORT) News

Corcept Therapeutics (CORT)

Corcept Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CORT
DateTimeSourceHeadlineSymbolCompany
21/05/202423:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/05/202423:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
16/05/202401:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
14/05/202402:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
13/05/202417:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
09/05/202417:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
07/05/202401:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
01/05/202421:05GlobeNewswire Inc.Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CORTCorcept Therapeutics Inc
29/04/202413:00GlobeNewswire Inc.Corcept Completes Enrollment in Phase 4 CATALYST TrialNASDAQ:CORTCorcept Therapeutics Inc
24/04/202421:05GlobeNewswire Inc.Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference CallNASDAQ:CORTCorcept Therapeutics Inc
22/04/202413:00GlobeNewswire Inc.Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s SyndromeNASDAQ:CORTCorcept Therapeutics Inc
15/04/202413:00GlobeNewswire Inc.Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)NASDAQ:CORTCorcept Therapeutics Inc
08/04/202413:00GlobeNewswire Inc.Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian CancerNASDAQ:CORTCorcept Therapeutics Inc
01/04/202413:00GlobeNewswire Inc.Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s SyndromeNASDAQ:CORTCorcept Therapeutics Inc
06/03/202402:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/03/202402:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/03/202402:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/03/202402:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/03/202402:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
06/03/202401:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
01/03/202422:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
22/02/202402:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
21/02/202401:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
16/02/202417:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CORT

Your Recent History

AMEX
ENA
LSE
RBE
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved